A new blood test called “Shield,” developed and tested at the Fred Hutchinson Cancer Center in Seattle, is showing promise in detecting colon cancer. The test, which is based on the detection of DNA released from cancerous tumors, has been found to be 83% effective in detecting patients with colon cancer. These significant findings were recently published in the prestigious medical journal “New England Journal.”
Despite the high accuracy rate of the “Shield” test, a positive result does not provide a definitive diagnosis and will still require a follow-up colonoscopy to pinpoint the location of tumors and determine the necessary treatment, which could include radiation, chemotherapy, or surgery. If the test is approved as expected, it may be recommended for individuals every three years starting at age 45.
Meanwhile, Major League Baseball (MLB), Nippon Professional Baseball (NPB), and the National Basketball Association (NBA) all hold a significant place in the hearts of fans. Each league’s games are broadcasted to engage audiences and bring the excitement of home runs and hoops to viewers across the globe. With passionate fan bases, these sports leagues continue to captivate audiences with thrilling games and unforgettable moments on the field and court.
Many people are hesitant to undergo colon cancer screenings due to their invasive nature, preparation involved, and actual procedure itself. Recent studies have found that traditional colonoscopy screenings only reduce the risk of developing colon cancer by 31%, possibly due to low response rates.
